Back to AQR CAPITAL MANAGEMENT LLC AQR CAPITAL MANAGEMENT LLC

PBYIPBYI
7 quarters

Position history for AQR CAPITAL MANAGEMENT LLCAQR CAPITAL MANAGEMENT LLC's holdings in PUMA BIOTECHNOLOGY INC

AQR CAPITAL MANAGEMENT LLC holds 725,192 shares of PBYI (PUMA BIOTECHNOLOGY INC), worth $5.9M as of 2026-Q2. The position was decreased (-9.4% shares). PBYI represents 0.0% of AQR CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$5.9M

Current Shares

725,192

Total Value Change

+$5.8M

Total Shares Change

+714,375

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
725,192
-9.4%
$5.9M0.0%$8.11
0
2026-Q1
Increased
800,194
+20.0%
$5.1M0.0%$6.21
32
2025-Q4
Increased
666,605
+410.1%
$4M0.0%$6.01
43
2025-Q3
Decreased
130,672
-7.8%
$693,8690.0%$5.05
0
2025-Q2
Increased
141,773
+181.0%
$486,2810.0%$3.33
39
2025-Q1
Increased
50,458
+366.5%
$149,3550.0%$3.14
36
2024-Q4
New
10,817
-
$32,9930.0%$3.13
30

Other major holders of PBYI: BLACKROCK ADVISORS LLC, FEDERATED HERMES, INC., BNP PARIBAS FINANCIAL MARKETS, FRED ALGER MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used